Terms: = Germ cell tumor AND ETV5, P41161, 2119, ENSG00000244405, ERM
73 results:
1. Visual and whole-body quantitative analyses of
Hotta M; Sonni I; Thin P; Nguyen K; Gardner L; Ciuca L; Hayrapetian A; Lewis M; Lubin D; Allen-Auerbach M
Ann Nucl Med; 2024 Apr; 38(4):296-304. PubMed ID: 38252228
[TBL] [Abstract] [Full Text] [Related]
2. Cooperative polarization of MCAM/CD146 and erm family proteins in melanoma.
Miller SG; Hoh M; Ebmeier CC; Tay JW; Ahn NG
Mol Biol Cell; 2024 Mar; 35(3):ar31. PubMed ID: 38117590
[TBL] [Abstract] [Full Text] [Related]
3. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers.
Velez G; Wolf J; Dufour A; Mruthyunjaya P; Mahajan VB
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):14. PubMed ID: 37955612
[TBL] [Abstract] [Full Text] [Related]
4. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
Lin W; Niu R; Park SM; Zou Y; Kim SS; Xia X; Xing S; Yang Q; Sun X; Yuan Z; Zhou S; Zhang D; Kwon HJ; Park S; Il Kim C; Koo H; Liu Y; Wu H; Zheng M; Yoo H; Shi B; Park JB; Yin J
Nat Commun; 2023 Mar; 14(1):1578. PubMed ID: 36949068
[TBL] [Abstract] [Full Text] [Related]
5. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract] [Full Text] [Related]
6. Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells.
Wang S; Zhang X; Zou X; Wen M; Gan C; Jiang X; Li M; Shen R; Zhu D; Yao A; Fang Y; Fox BA; Hu HM; Yu G; Wang X
Cancer Immunol Immunother; 2023 May; 72(5):1301-1313. PubMed ID: 36436020
[TBL] [Abstract] [Full Text] [Related]
7. Surgical outcome and pathological findings in macular epiretinal membrane caused by neurofibromatosis type 2.
Kunikata H; Nishiguchi KM; Watanabe M; Nakazawa T
Digit J Ophthalmol; 2022; 28(1):12-16. PubMed ID: 35573141
[TBL] [Abstract] [Full Text] [Related]
8. Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2.
Emmanouil B; Wasik M; Charbel Issa P; Halliday D; Parry A; Sharma SM
Ophthalmic Res; 2022; 65(1):77-85. PubMed ID: 34673638
[TBL] [Abstract] [Full Text] [Related]
9. Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.
Demir AB; Aktas S; Altun Z; Ercetin P; Aktas TC; Olgun N
Folia Biol (Praha); 2021; 67(1):1-9. PubMed ID: 34273261
[TBL] [Abstract] [Full Text] [Related]
10. Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma.
Ognibene M; Pezzolo A
PLoS One; 2020; 15(12):e0244069. PubMed ID: 33326488
[TBL] [Abstract] [Full Text] [Related]
11. CRISPR Screens Identify Essential cell Growth Mediators in BRAF Inhibitor-resistant Melanoma.
Li Z; Wang B; Gu S; Jiang P; Sahu A; Chen CH; Han T; Shi S; Wang X; Traugh N; Liu H; Liu Y; Wu Q; Brown M; Xiao T; Boland GM; Shirley Liu X
Genomics Proteomics Bioinformatics; 2020 Feb; 18(1):26-40. PubMed ID: 32413516
[TBL] [Abstract] [Full Text] [Related]
12. c-Src Phosphorylates and Inhibits the Function of the CIC tumor Suppressor Protein.
Bunda S; Heir P; Li ASC; Mamatjan Y; Zadeh G; Aldape K
Mol Cancer Res; 2020 May; 18(5):774-786. PubMed ID: 32029440
[TBL] [Abstract] [Full Text] [Related]
13. The ETS transcription factor etv5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
Mus LM; Lambertz I; Claeys S; Kumps C; Van Loocke W; Van Neste C; Umapathy G; Vaapil M; Bartenhagen C; Laureys G; De Wever O; Bexell D; Fischer M; Hallberg B; Schulte J; De Wilde B; Durinck K; Denecker G; De Preter K; Speleman F
Sci Rep; 2020 Jan; 10(1):218. PubMed ID: 31937834
[TBL] [Abstract] [Full Text] [Related]
14. Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology.
Derouiche A; Geiger KD
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382374
[TBL] [Abstract] [Full Text] [Related]
15. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract] [Full Text] [Related]
16. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract] [Full Text] [Related]
17. Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
McEvoy CR; Xu H; Smith K; Etemadmoghadam D; San Leong H; Choong DY; Byrne DJ; Iravani A; Beck S; Mileshkin L; Tothill RW; Bowtell DD; Bates BM; Nastevski V; Browning J; Bell AH; Khoo C; Desai J; Fellowes AP; Fox SB; Prall OW
J Clin Invest; 2019 May; 129(5):1940-1945. PubMed ID: 30835257
[TBL] [Abstract] [Full Text] [Related]
18. Graph complexity analysis identifies an etv5 tumor-specific network in human and murine low-grade glioma.
Pan Y; Duron C; Bush EC; Ma Y; Sims PA; Gutmann DH; Radunskaya A; Hardin J
PLoS One; 2018; 13(5):e0190001. PubMed ID: 29787563
[TBL] [Abstract] [Full Text] [Related]
19. Activated ALK signals through the ERK-etv5-RET pathway to drive neuroblastoma oncogenesis.
Lopez-Delisle L; Pierre-Eugène C; Louis-Brennetot C; Surdez D; Raynal V; Baulande S; Boeva V; Grossetête-Lalami S; Combaret V; Peuchmaur M; Delattre O; Janoueix-Lerosey I
Oncogene; 2018 Mar; 37(11):1417-1429. PubMed ID: 29321660
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.
Lee SY; Zhu J; Salzberg AC; Zhang B; Liu DJ; Muscat JE; Langan ST; Connor JR
PLoS One; 2017; 12(3):e0174778. PubMed ID: 28358914
[TBL] [Abstract] [Full Text] [Related]
[Next]
